Product Information
VIVITROL 380 MG VIAL-DILUENT is a brand product labeled by Alkermes, Inc., priced at $1716.4843 per EA under NDC 65757030001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 13, 2006.
Manufacturer
Alkermes, Inc.NDC
65757030001
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA021897FDA Approved
4/13/2006
On Market Since
6/13/2006
Price Statistics
The NADAC for VIVITROL 380 MG VIAL-DILUENT has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1716.4843 per EA |
|---|---|
| All-time high | $1719.4648 (May 13, 2026) |
| All-time low | $1068.5812 (Jan 22, 2014) |
| 52-week high | $1719.4648 |
| 52-week low | $1621.4905 |
| Median price | $1272.3508 |
| Average price | $1368.1415 |
| Largest weekly change | +10.0% (Dec 17, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naltrexone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VIVITROL 380 MG VIAL-DILUENT?
The current National Average Drug Acquisition Cost (NADAC) for VIVITROL 380 MG VIAL-DILUENT, manufactured by Alkermes, Inc., is $1716.4843 per EA (NDC 65757030001), effective Aug 19, 2026.
How has the price of VIVITROL 380 MG VIAL-DILUENT changed over time?
Over the history we have for it, the NADAC for VIVITROL 380 MG VIAL-DILUENT has risen 59.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VIVITROL 380 MG VIAL-DILUENT?
Since Nov 28, 2013, the NADAC for VIVITROL 380 MG VIAL-DILUENT has ranged from a low of $1068.5812 (Jan 22, 2014) to a high of $1719.4648 (May 13, 2026), with a median of $1272.3508 per EA.
Are there cheaper alternatives to VIVITROL 380 MG VIAL-DILUENT?
No other NADAC-published product currently shares the active ingredient and strength of VIVITROL 380 MG VIAL-DILUENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIVITROL 380 MG VIAL-DILUENT?
VIVITROL 380 MG VIAL-DILUENT (NDC 65757030001) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.